home / stock / cara / cara quote
Last: | $0.6716 |
---|---|
Change Percent: | -1.33% |
Open: | $0.7165 |
Close: | $0.6716 |
High: | $0.72 |
Low: | $0.6613 |
Volume: | 215,512 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6716 | $0.7165 | $0.6716 | $0.72 | $0.6613 | 215,512 | 04-24-2024 |
$0.7071 | $0.7187 | $0.7071 | $0.73 | $0.7 | 181,886 | 04-23-2024 |
$0.7304 | $0.66 | $0.7304 | $0.7394 | $0.65 | 346,171 | 04-22-2024 |
$0.661 | $0.685 | $0.661 | $0.6958 | $0.65 | 351,866 | 04-19-2024 |
$0.69 | $0.73 | $0.69 | $0.7361 | $0.68 | 363,143 | 04-18-2024 |
$0.7319 | $0.709 | $0.7319 | $0.7481 | $0.7 | 184,648 | 04-17-2024 |
$0.709 | $0.71 | $0.709 | $0.7175 | $0.6311 | 603,079 | 04-16-2024 |
$0.71 | $0.765 | $0.71 | $0.7839 | $0.7 | 440,107 | 04-15-2024 |
$0.7641 | $0.81 | $0.7641 | $0.83 | $0.7574 | 306,332 | 04-12-2024 |
$0.8106 | $0.8015 | $0.8106 | $0.8289 | $0.8015 | 214,481 | 04-11-2024 |
$0.812 | $0.825 | $0.812 | $0.8263 | $0.8043 | 357,431 | 04-10-2024 |
$0.832 | $0.8536 | $0.832 | $0.8592 | $0.82 | 272,487 | 04-09-2024 |
$0.8255 | $0.8615 | $0.8255 | $0.88 | $0.7355 | 579,095 | 04-08-2024 |
$0.8745 | $0.8258 | $0.8745 | $0.8945 | $0.812 | 453,410 | 04-05-2024 |
$0.8258 | $0.9174 | $0.8258 | $0.945 | $0.81 | 471,588 | 04-04-2024 |
$0.9074 | $0.94 | $0.9074 | $0.949 | $0.8778 | 318,552 | 04-03-2024 |
$0.9195 | $0.9053 | $0.9195 | $0.929 | $0.89 | 270,408 | 04-02-2024 |
$0.91 | $0.9114 | $0.91 | $0.9402 | $0.86 | 328,963 | 04-01-2024 |
$0.91 | $0.853 | $0.91 | $0.96 | $0.85 | 637,279 | 03-29-2024 |
$0.91 | $0.853 | $0.91 | $0.96 | $0.85 | 637,279 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
NASDAQ Market:
Cara Therapeutics Inc. Website:
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a development-stage biopharmaceutical company leadin...
STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a development-stage biopharmaceutical company leadin...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quar...